Imperial College London
Portrait Picture

ProfessorPaulKellam

Faculty of Medicine, Department of Infectious Disease

Professor of Virus Genomics
 
 
 
//

Contact

 

p.kellam

 
 
//

Location

 

460Wright Fleming WingSt Mary's Campus

//

Summary

 

Publications

Citation

BibTex format

@article{Maes:2020:10.1038/s41598-020-69300-8,
author = {Maes, M and Dyson, ZA and Smith, SE and Goulding, DA and Ludden, C and Baker, S and Kellam, P and Reece, ST and Dougan, G and Scott, JB},
doi = {10.1038/s41598-020-69300-8},
journal = {Scientific Reports},
title = {A novel therapeutic antibody screening method using bacterial high-content imaging reveals functional antibody binding phenotypes of Escherichia coli ST131},
url = {http://dx.doi.org/10.1038/s41598-020-69300-8},
volume = {10},
year = {2020}
}
Download

RIS format (EndNote, RefMan)

TY  - JOUR
AB  - The increase of antimicrobial resistance (AMR), and lack of new classes of licensed antimicrobials, have made alternative treatment options for AMR pathogens increasingly attractive. Recent studies have demonstrated anti-bacterial efficacy of a humanised monoclonal antibody (mAb) targeting the O25b O-antigen of Escherichia coli ST131. To evaluate the phenotypic effects of antibody binding to diverse clinical E. coli ST131 O25b bacterial isolates in high-throughput, we designed a novel mAb screening method using high-content imaging (HCI) and image-based morphological profiling to screen a mAb targeting the O25b O-antigen. Screening the antibody against a panel of 86 clinical E. coli ST131 O25:H4 isolates revealed 4 binding phenotypes: no binding (18.60%), weak binding (4.65%), strong binding (69.77%) and strong agglutinating binding (6.98%). Impaired antibody binding could be explained by the presence of insertion sequences or mutations in O-antigen or lipopolysaccharide core biosynthesis genes, affecting the amount, structure or chain length of the O-antigen. The agglutinating binding phenotype was linked with lower O-antigen density, enhanced antibody-mediated phagocytosis and increased serum susceptibly. This study highlights the need to screen candidate mAbs against large panels of clinically relevant isolates, and that HCI can be used to evaluate mAb binding affinity and potential functional efficacy against AMR bacteria.
AU  - Maes,M
AU  - Dyson,ZA
AU  - Smith,SE
AU  - Goulding,DA
AU  - Ludden,C
AU  - Baker,S
AU  - Kellam,P
AU  - Reece,ST
AU  - Dougan,G
AU  - Scott,JB
DO  - 10.1038/s41598-020-69300-8
PY  - 2020///
SN  - 2045-2322
TI  - A novel therapeutic antibody screening method using bacterial high-content imaging reveals functional antibody binding phenotypes of Escherichia coli ST131
T2  - Scientific Reports
UR  - http://dx.doi.org/10.1038/s41598-020-69300-8
UR  - https://www.ncbi.nlm.nih.gov/pubmed/32709982
UR  - http://hdl.handle.net/10044/1/81378
VL  - 10
ER  -
Download